Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 80

1.

Concepts Collide: Genomic, Immune, and Microbial Influences on the Tumor Microenvironment and Response to Cancer Therapy.

Andrews MC, Reuben A, Gopalakrishnan V, Wargo JA.

Front Immunol. 2018 May 4;9:946. doi: 10.3389/fimmu.2018.00946. eCollection 2018. Review.

2.

Autoantibodies May Predict Immune-Related Toxicity: Results from a Phase I Study of Intralesional Bacillus Calmette-Guérin followed by Ipilimumab in Patients with Advanced Metastatic Melanoma.

Da Gama Duarte J, Parakh S, Andrews MC, Woods K, Pasam A, Tutuka C, Ostrouska S, Blackburn JM, Behren A, Cebon J.

Front Immunol. 2018 Mar 2;9:411. doi: 10.3389/fimmu.2018.00411. eCollection 2018.

3.

Modulation of the carboxamidine redox potential through photoinduced spiropyran or fulgimide isomerisation.

Andrews MC, Peng P, Rajput A, Cozzolino AF.

Photochem Photobiol Sci. 2018 Apr 18;17(4):432-441. doi: 10.1039/c7pp00347a.

PMID:
29528073
4.

The RNA-binding Protein MEX3B Mediates Resistance to Cancer Immunotherapy by Downregulating HLA-A Expression.

Huang L, Malu S, McKenzie JA, Andrews MC, Talukder AH, Tieu T, Karpinets T, Haymaker C, Forget MA, Williams LJ, Wang Z, Mbofung RM, Wang ZQ, Davis RE, Lo RS, Wargo JA, Davies MA, Bernatchez C, Heffernan T, Amaria RN, Korkut A, Peng W, Roszik J, Lizée G, Woodman SE, Hwu P.

Clin Cancer Res. 2018 Jul 15;24(14):3366-3376. doi: 10.1158/1078-0432.CCR-17-2483. Epub 2018 Mar 1.

PMID:
29496759
5.

The good, the (not so) bad and the ugly of immune homeostasis in melanoma.

da Gama Duarte J, Woods K, Andrews MC, Behren A.

Immunol Cell Biol. 2018 May;96(5):497-506. doi: 10.1111/imcb.12001. Epub 2018 Feb 2. Review.

PMID:
29392770
6.

Neoadjuvant plus adjuvant dabrafenib and trametinib versus standard of care in patients with high-risk, surgically resectable melanoma: a single-centre, open-label, randomised, phase 2 trial.

Amaria RN, Prieto PA, Tetzlaff MT, Reuben A, Andrews MC, Ross MI, Glitza IC, Cormier J, Hwu WJ, Tawbi HA, Patel SP, Lee JE, Gershenwald JE, Spencer CN, Gopalakrishnan V, Bassett R, Simpson L, Mouton R, Hudgens CW, Zhao L, Zhu H, Cooper ZA, Wani K, Lazar A, Hwu P, Diab A, Wong MK, McQuade JL, Royal R, Lucci A, Burton EM, Reddy S, Sharma P, Allison J, Futreal PA, Woodman SE, Davies MA, Wargo JA.

Lancet Oncol. 2018 Feb;19(2):181-193. doi: 10.1016/S1470-2045(18)30015-9. Epub 2018 Jan 18.

PMID:
29361468
7.

Cancer Evolution during Immunotherapy.

Andrews MC, Wargo JA.

Cell. 2017 Nov 2;171(4):740-742. doi: 10.1016/j.cell.2017.10.027.

PMID:
29100071
8.

Gut microbiome modulates response to anti-PD-1 immunotherapy in melanoma patients.

Gopalakrishnan V, Spencer CN, Nezi L, Reuben A, Andrews MC, Karpinets TV, Prieto PA, Vicente D, Hoffman K, Wei SC, Cogdill AP, Zhao L, Hudgens CW, Hutchinson DS, Manzo T, Petaccia de Macedo M, Cotechini T, Kumar T, Chen WS, Reddy SM, Szczepaniak Sloane R, Galloway-Pena J, Jiang H, Chen PL, Shpall EJ, Rezvani K, Alousi AM, Chemaly RF, Shelburne S, Vence LM, Okhuysen PC, Jensen VB, Swennes AG, McAllister F, Marcelo Riquelme Sanchez E, Zhang Y, Le Chatelier E, Zitvogel L, Pons N, Austin-Breneman JL, Haydu LE, Burton EM, Gardner JM, Sirmans E, Hu J, Lazar AJ, Tsujikawa T, Diab A, Tawbi H, Glitza IC, Hwu WJ, Patel SP, Woodman SE, Amaria RN, Davies MA, Gershenwald JE, Hwu P, Lee JE, Zhang J, Coussens LM, Cooper ZA, Futreal PA, Daniel CR, Ajami NJ, Petrosino JF, Tetzlaff MT, Sharma P, Allison JP, Jenq RR, Wargo JA.

Science. 2018 Jan 5;359(6371):97-103. doi: 10.1126/science.aan4236. Epub 2017 Nov 2.

9.

Distinct Cellular Mechanisms Underlie Anti-CTLA-4 and Anti-PD-1 Checkpoint Blockade.

Wei SC, Levine JH, Cogdill AP, Zhao Y, Anang NAS, Andrews MC, Sharma P, Wang J, Wargo JA, Pe'er D, Allison JP.

Cell. 2017 Sep 7;170(6):1120-1133.e17. doi: 10.1016/j.cell.2017.07.024. Epub 2017 Aug 10.

10.

PLX8394, a new generation BRAF inhibitor, selectively inhibits BRAF in colonic adenocarcinoma cells and prevents paradoxical MAPK pathway activation.

Tutuka CSA, Andrews MC, Mariadason JM, Ioannidis P, Hudson C, Cebon J, Behren A.

Mol Cancer. 2017 Jun 28;16(1):112. doi: 10.1186/s12943-017-0684-x.

11.

Targeting endothelin receptor signalling overcomes heterogeneity driven therapy failure.

Smith MP, Rowling EJ, Miskolczi Z, Ferguson J, Spoerri L, Haass NK, Sloss O, McEntegart S, Arozarena I, von Kriegsheim A, Rodriguez J, Brunton H, Kmarashev J, Levesque MP, Dummer R, Frederick DT, Andrews MC, Cooper ZA, Flaherty KT, Wargo JA, Wellbrock C.

EMBO Mol Med. 2017 Aug;9(8):1011-1029. doi: 10.15252/emmm.201607156.

12.

Efficacy of anti-PD-1 therapy in patients with melanoma brain metastases.

Parakh S, Park JJ, Mendis S, Rai R, Xu W, Lo S, Drummond M, Rowe C, Wong A, McArthur G, Haydon A, Andrews MC, Cebon J, Guminski A, Kefford RF, Long GV, Menzies AM, Klein O, Carlino MS.

Br J Cancer. 2017 Jun 6;116(12):1558-1563. doi: 10.1038/bjc.2017.142. Epub 2017 May 18.

13.

Hallmarks of response to immune checkpoint blockade.

Cogdill AP, Andrews MC, Wargo JA.

Br J Cancer. 2017 Jun 27;117(1):1-7. doi: 10.1038/bjc.2017.136. Epub 2017 May 18. Review.

14.

Reply to 'Comment on 'Efficacy and toxicity of treatment with the anti-CTLA-4 antibody ipilimumab in patients with metastatic melanoma after prior anti-PD-1 therapy''.

Bowyer S, Prithviraj P, Lorigan P, Larkin J, McArthur G, Atkinson V, Millward M, Khou M, Diem S, Ramanujam S, Kong B, Liniker E, Guminski A, Parente P, Andrews MC, Parakh S, Cebon J, Long GV, Carlino MS, Klein O.

Br J Cancer. 2017 Apr 11;116(8):e15. doi: 10.1038/bjc.2017.59. Epub 2017 Mar 21. No abstract available.

15.

Immunotherapy resistance: the answers lie ahead - not in front - of us.

Andrews MC, Wargo JA.

J Immunother Cancer. 2017 Feb 21;5:10. doi: 10.1186/s40425-017-0212-y. eCollection 2017.

16.

Systems analysis identifies miR-29b regulation of invasiveness in melanoma.

Andrews MC, Cursons J, Hurley DG, Anaka M, Cebon JS, Behren A, Crampin EJ.

Mol Cancer. 2016 Nov 16;15(1):72.

17.

Late presentation of generalised bullous pemphigoid-like reaction in a patient treated with pembrolizumab for metastatic melanoma.

Parakh S, Nguyen R, Opie JM, Andrews MC.

Australas J Dermatol. 2017 Aug;58(3):e109-e112. doi: 10.1111/ajd.12488. Epub 2016 May 11.

PMID:
27170423
18.

Efficacy and toxicity of treatment with the anti-CTLA-4 antibody ipilimumab in patients with metastatic melanoma after prior anti-PD-1 therapy.

Bowyer S, Prithviraj P, Lorigan P, Larkin J, McArthur G, Atkinson V, Millward M, Khou M, Diem S, Ramanujam S, Kong B, Liniker E, Guminski A, Parente P, Andrews MC, Parakh S, Cebon J, Long GV, Carlino MS, Klein O.

Br J Cancer. 2016 May 10;114(10):1084-9. doi: 10.1038/bjc.2016.107. Epub 2016 Apr 28.

19.

Non-HIV-associated Kaposi sarcoma in an immunosuppressed melanoma patient treated with dabrafenib.

Parakh S, Goh M, Andrews MC.

J Clin Pharm Ther. 2016 Jun;41(3):354-356. doi: 10.1111/jcpt.12366. Epub 2016 Feb 28.

PMID:
26922422
20.

Room for Improvement in Nutrition Knowledge and Dietary Intake of Male Football (Soccer) Players in Australia.

Andrews MC, Itsiopoulos C.

Int J Sport Nutr Exerc Metab. 2016 Feb;26(1):55-64. doi: 10.1123/ijsnem.2015-0064. Epub 2015 Aug 3.

PMID:
26251549
21.

Cellular Mechanisms Underlying Complete Hematological Response of Chronic Myeloid Leukemia to BRAF and MEK1/2 Inhibition in a Patient with Concomitant Metastatic Melanoma.

Andrews MC, Turner N, Boyd J, Roberts AW, Grigg AP, Behren A, Cebon J.

Clin Cancer Res. 2015 Dec 1;21(23):5222-34. doi: 10.1158/1078-0432.CCR-15-0393. Epub 2015 Jul 22.

22.

The kinase inhibitors dabrafenib and trametinib affect isolated immune cell populations.

Vella LJ, Andrews MC, Pasam A, Woods K, Behren A, Cebon JS.

Oncoimmunology. 2014 Jul 3;3(7):e946367. eCollection 2014.

23.

Effects of epithelial to mesenchymal transition on T cell targeting of melanoma cells.

Woods K, Pasam A, Jayachandran A, Andrews MC, Cebon J.

Front Oncol. 2014 Dec 17;4:367. doi: 10.3389/fonc.2014.00367. eCollection 2014. Review.

24.

Response to MAPK pathway inhibitors in BRAF V600M-mutated metastatic melanoma.

Parakh S, Murphy C, Lau D, Cebon JS, Andrews MC.

J Clin Pharm Ther. 2015 Feb;40(1):121-3. doi: 10.1111/jcpt.12229. Epub 2014 Nov 10.

PMID:
25382067
25.

Plant food anthocyanins inhibit platelet granule secretion in hypercholesterolaemia: Involving the signalling pathway of PI3K-Akt.

Song F, Zhu Y, Shi Z, Tian J, Deng X, Ren J, Andrews MC, Ni H, Ling W, Yang Y.

Thromb Haemost. 2014 Nov;112(5):981-91. doi: 10.1160/TH13-12-1002. Epub 2014 Jul 31.

PMID:
25077916
26.

Evolving role of tumor antigens for future melanoma therapies.

Andrews MC, Woods K, Cebon J, Behren A.

Future Oncol. 2014 Jun;10(8):1457-68. doi: 10.2217/fon.14.84. Review.

PMID:
25052755
27.

Immune consequences of kinase inhibitors in development, undergoing clinical trials and in current use in melanoma treatment.

Vella LJ, Andrews MC, Behren A, Cebon J, Woods K.

Expert Rev Clin Immunol. 2014 Aug;10(8):1107-23. doi: 10.1586/1744666X.2014.929943. Epub 2014 Jun 17. Review.

PMID:
24939732
28.

A single-centre experience of patients with metastatic melanoma enrolled in a dabrafenib named patient programme.

Lau DK, Andrews MC, Turner N, Azad AA, Davis ID, Cebon JS.

Melanoma Res. 2014 Apr;24(2):144-9. doi: 10.1097/CMR.0000000000000036.

PMID:
24463460
29.

BRAF inhibitor-driven tumor proliferation in a KRAS-mutated colon carcinoma is not overcome by MEK1/2 inhibition.

Andrews MC, Behren A, Chionh F, Mariadason J, Vella LJ, Do H, Dobrovic A, Tebbutt N, Cebon J.

J Clin Oncol. 2013 Dec 10;31(35):e448-51. doi: 10.1200/JCO.2013.50.4118. Epub 2013 Nov 4. No abstract available.

PMID:
24190114
30.

Peer health education in Haiti's National Penitentiary: the "Health through Walls" experience.

Zack B, Smith C, Andrews MC, May JP.

J Correct Health Care. 2013 Jan;19(1):65-8. doi: 10.1177/1078345812458258.

PMID:
23275447
31.

Plant food delphinidin-3-glucoside significantly inhibits platelet activation and thrombosis: novel protective roles against cardiovascular diseases.

Yang Y, Shi Z, Reheman A, Jin JW, Li C, Wang Y, Andrews MC, Chen P, Zhu G, Ling W, Ni H.

PLoS One. 2012;7(5):e37323. doi: 10.1371/journal.pone.0037323. Epub 2012 May 18.

32.

Anthocyanin extract from black rice significantly ameliorates platelet hyperactivity and hypertriglyceridemia in dyslipidemic rats induced by high fat diets.

Yang Y, Andrews MC, Hu Y, Wang D, Qin Y, Zhu Y, Ni H, Ling W.

J Agric Food Chem. 2011 Jun 22;59(12):6759-64. doi: 10.1021/jf201079h. Epub 2011 Jun 1.

PMID:
21568342
33.

Characterising metabolic resistance in pyrethroid-insensitive pollen beetle (Meligethes aeneus F.) from Poland and Switzerland.

Philippou D, Field LM, Wegorek P, Zamojska J, Andrews MC, Slater R, Moores GD.

Pest Manag Sci. 2011 Feb;67(2):239-43. doi: 10.1002/ps.2061.

PMID:
21104794
34.

Got political skill? The impact of justice on the importance of political skill for job performance.

Andrews MC, Kacmar KM, Harris KJ.

J Appl Psychol. 2009 Nov;94(6):1427-37. doi: 10.1037/a0017154.

PMID:
19916653
35.

Nramp1 promotes efficient macrophage recycling of iron following erythrophagocytosis in vivo.

Soe-Lin S, Apte SS, Andriopoulos B Jr, Andrews MC, Schranzhofer M, Kahawita T, Garcia-Santos D, Ponka P.

Proc Natl Acad Sci U S A. 2009 Apr 7;106(14):5960-5. doi: 10.1073/pnas.0900808106. Epub 2009 Mar 24.

36.

Antioxidant vitamins and adrenocorticotrophic hormone-induced hypertension in rats.

Schyvens CG, Andrews MC, Tam R, Mori TA, Croft KD, McKenzie KU, Whitworth JA, Zhang Y.

Clin Exp Hypertens. 2007 Oct;29(7):465-78.

PMID:
17994356
37.

Short term changes in melatonin and cortisol serum levels after a single administration of estrogen to menopausal women.

Kerdelhué B, Andrews MC, Zhao Y, Scholler R, Jones HW Jr.

Neuro Endocrinol Lett. 2006 Oct;27(5):659-64.

PMID:
17159819
38.

Acetylcholinesterase genes and insecticide resistance in aphids.

Dong SL, Andrews MC, Li F, Moores GD, Han ZJ, Williamson MS.

Chem Biol Interact. 2005 Dec 15;157-158:373-4. No abstract available.

PMID:
16429498
39.

Apocynin but not allopurinol prevents and reverses adrenocorticotropic hormone-induced hypertension in the rat.

Zhang Y, Chan MM, Andrews MC, Mori TA, Croft KD, McKenzie KU, Schyvens CG, Whitworth JA.

Am J Hypertens. 2005 Jul;18(7):910-6.

PMID:
16053986
40.

Nitric oxide donation lowers blood pressure in adrenocorticotrophic hormone-induced hypertensive rats.

Andrews MC, Schyvens CG, Zhang Y, McKenzie KU, Whitworth JA.

Clin Exp Hypertens. 2004 Aug;26(6):499-509.

PMID:
15554453
41.

Identification of mutations conferring insecticide-insensitive AChE in the cotton-melon aphid, Aphis gossypii Glover.

Andrews MC, Callaghan A, Field LM, Williamson MS, Moores GD.

Insect Mol Biol. 2004 Oct;13(5):555-61.

PMID:
15373812
42.

Adrenocorticotropic hormone, blood pressure, and serum erythropoietin concentrations in the rat.

Zhang Y, Andrews MC, Schyvens CG, McKenzie KU, Whitworth JA.

Am J Hypertens. 2004 May;17(5 Pt 1):457-61.

PMID:
15110907
43.

The nitric oxide system in glucocorticoid-induced hypertension.

Whitworth JA, Schyvens CG, Zhang Y, Andrews MC, Mangos GJ, Kelly JJ.

J Hypertens. 2002 Jun;20(6):1035-43. Review.

PMID:
12023661
44.

Phosphorus uptake into algal biofilms in a lowland chalk river.

Jarvi HP, Neal C, Warwick A, White J, Neal M, Wickham HD, Hill LK, Andrews MC.

Sci Total Environ. 2002 Jan 23;282-283:353-73.

PMID:
11846079
45.

The psychological status at school age of children conceived by in-vitro fertilization.

Montgomery TR, Aiello F, Adelman RD, Wasylyshyn N, Andrews MC, Brazelton TB, Jones GS, Jones HW Jr.

Hum Reprod. 1999 Aug;14(8):2162-5.

PMID:
10438444
46.

Primary care for postreproductive women: further thoughts concerning steroid replacement.

Andrews MC.

Am J Obstet Gynecol. 1994 Apr;170(4):963-6. No abstract available.

PMID:
8166216
47.

The absorption of oral micronized progesterone: the effect of food, dose proportionality, and comparison with intramuscular progesterone.

Simon JA, Robinson DE, Andrews MC, Hildebrand JR 3rd, Rocci ML Jr, Blake RE, Hodgen GD.

Fertil Steril. 1993 Jul;60(1):26-33.

PMID:
8513955
48.

Papillary peritoneal carcinomatosis after prophylactic oophorectomy.

Kemp GM, Hsiu JG, Andrews MC.

Gynecol Oncol. 1992 Dec;47(3):395-7.

PMID:
1473756
49.

Sutter lesser toe implant.

Sgarlato TE, Carine TA, Andrews MC.

J Am Podiatr Med Assoc. 1988 Jul;78(7):335-8. No abstract available.

PMID:
3404409
50.

L- and M-shell x-ray production cross sections of Nd, Gd, Ho, Yb, Au, and Pb by 25-MeV carbon and 32-MeV oxygen ions.

Andrews MC, McDaniel FD, Duggan JL, Miller PD, Pepmiller PL, Krause HF, Rosseel TM, Rayburn LA, Mehta R, Lapicki G.

Phys Rev A Gen Phys. 1987 Oct 15;36(8):3699-3706. No abstract available.

PMID:
9899304

Supplemental Content

Loading ...
Support Center